Clinical Trial

Head to Head Trial of Mailed Cologuard to Mailed FIT

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The objective of this study is to measure the comparative effectiveness of mailed outreach of two stool based tests, multi-target stool DNA (Cologuard) and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-09; most recent amendment 2025-09-05.
Trial Details
NCT Number NCT06931860
Lead Sponsor University of California, San Diego
Collaborators: National Cancer Institute (NCI)
Conditions Colorectal Cancer Screening, Fecal Immunochemical Test, Multi-target Stool DNA, Colorectal Cancer (CRC)
Enrollment 400 participants
Start Date 2025-09-05
Primary Completion 2026-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-09